Table 3.
Serum zinc levels of patients with gastric cancer organized by clinical variables
| Variable | Serum zinc level, μg/dL | p value |
|---|---|---|
| Age | ||
| <74 years | 76 (38–152) | 0.002 |
| ≥74 years | 71 (20–93) | |
| Sex | ||
| Male | 74 (43–152) | 0.524 |
| Female | 71 (20–135) | |
| Body mass index | ||
| <22.2 | 72 (20–152) | 0.311 |
| ≥22.2 | 75 (43–133) | |
| Peak expiratory flow rate, L/sec | ||
| <5.3 | 72 (20–135) | 0.419 |
| ≥5.3 | 73 (47–152) | |
| Serum H. pylori antibody | ||
| Positive | 72 (48–133) | 0.704 |
| Negative | 75 (20–152) | |
| Neutrophil count, mm3 | ||
| <3,805 | 73 (38–152) | 0.957 |
| ≥3,805 | 73 (20–133) | |
| Lymphocyte count, mm3 | ||
| <1,600 | 73 (20–135) | 0.086 |
| ≥1,600 | 74 (47–152) | |
| Albumin, g/dL | ||
| <4.1 | 69 (20–135) | <0.001 |
| ≥4.1 | 82 (48–152) | |
| C-reactive protein, mg/dL | ||
| <0.12 | 77 (43–135) | 0.100 |
| ≥0.12 | 72 (20–152) | |
| Neutrophil-to-lymphocyte ratio | ||
| < 2.37 | 75 (43–152) | 0.012 |
| ≥ 2.37 | 72.5 (20–99) | |